Objective: To evaluate the outcomes after cystectomy for ulcerative interstitial cystitis (IC).

Methods: Medical records were reviewed for history, operative data, and postoperative events. A mailed survey assessed preoperative symptom severity/duration, providers seen, and symptom changes on 7-point scaled global response assessments. Descriptive statistics were performed.

Results: Of 10 women (mean age 64 ± 12.5 years), 9 had cystectomy with ileal conduit and 1 had a neobladder. All had previous cautery of Hunner's ulcer (median 3.0 cautery procedures). Maximum bladder capacity at first and last cautery was median 325 and 188 mL, respectively. Median operative time was 321 minutes, blood loss was 200 mL (range, 100-900), 4 of 10 were transfused, and length of stay was 8 days. During a mean follow-up of 3.9 years, 6 patients required 1 or more reoperations, including hernia repair (2), urostomy revision (2), revision of ureteroileal anastomosis (1), small bowel resection (1), and neobladder cutaneous fistula repair (1). Survey respondents (n = 9) reported having seen (mean) 5.4 ± 3.8 providers before cystectomy. Median duration of symptoms was 5 years, and day and nighttime urinary frequencies were 30 and 15 times, respectively. Postoperatively, IC pain had resolved in all patients except for one. On the global response assessments, patients had moderate/marked improvement in overall symptoms (8 of 8), pain (9 of 9), sexual function (4 of 6), and quality of life (8 of 9), 7 of 9 were very satisfied with the treatment, and 8 of 9 would make the same decision again.

Conclusion: Despite subsequent reoperations, symptom improvements lead to high levels of satisfaction with cystectomy for IC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.06.043DOI Listing

Publication Analysis

Top Keywords

cystectomy ulcerative
8
ulcerative interstitial
8
interstitial cystitis
8
global response
8
response assessments
8
cystectomy
5
cystitis sequelae
4
sequelae patients'
4
patients' perceptions
4
perceptions improvement
4

Similar Publications

The use of radiotherapy has increased in recent years, especially for pelvic neoplasms, and this can result in long-term complications such as recurrent haemorrhagic radiation cystitis (RHC). A 73-year-old male patient presented to a hospital emergency department multiple times with visible haematuria and clots leading to urinary clot retention; he was finally diagnosed with RHC. During the last presentation, the bladder was irrigated continuously with saline using a three-way catheter.

View Article and Find Full Text PDF
Article Synopsis
  • Neoadjuvant chemotherapy (NACT) is recommended for treating muscle-invasive bladder cancer, but the current guidelines for examining specimens after treatment are unclear.
  • A survey conducted among pathologists and their assistants revealed that gross tumors are often not identified, with 29% of cases showing no gross lesions at all.
  • There is a strong interest among responders for standardized protocols in examining and reporting post-NACT cystectomies to improve consistency in practice.
View Article and Find Full Text PDF

A case of rare metachronous four primary carcinoma.

J Cancer Res Clin Oncol

August 2023

Department of General Surgery, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China.

Purpose: When more than two tumors are diagnosed in the same person, it is called multiple primary cancer. It is rare to be diagnosed as four primary cancers. Here, we present one elderly male patient suffered from testicular seminoma, gastric cancer, bladder cancer and breast cancer from 1946 to 2019.

View Article and Find Full Text PDF
Article Synopsis
  • * A case involving a 72-year-old woman illustrated this rarity; she presented with gross hematuria and abdominal pain, leading to the discovery of a mucinous adenocarcinoma that infiltrated her urinary bladder.
  • * The treatment involved surgery to remove the cancerous appendix along with affected portions of the bladder and surrounding tissues, and the patient had a smooth recovery with no signs of recurrence after 9 months.
View Article and Find Full Text PDF
Article Synopsis
  • - Cutaneous metastatic breast cancer, particularly "Carcinoma Erysipeloides," involves the invasion of skin layers via lymphatic spread and can be difficult to diagnose due to varied presentation like papules, plaques, or ulcerations, often occurring in areas such as the chest and scalp.
  • - A case study highlights a 45-year-old Hispanic woman with metastatic breast cancer post-chemotherapy and treatment with trastuzumab, showcasing the importance of thorough diagnosis monitoring for distant spread, as skin metastasis can signal advanced disease.
  • - Recent studies suggest that trastuzumab deruxtecan may be more effective than trastuzumab emtansine, promoting lower progression and mortality rates, while understanding clinical variations in skin lesions is
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!